Literature DB >> 14755452

The gender effect in juvenile Huntington disease patients of Italian origin.

Milena Cannella1, Cinzia Gellera, Vittorio Maglione, Patrizia Giallonardo, Giuliana Cislaghi, Maria Muglia, Aldo Quattrone, Francesco Pierelli, Stefano Di Donato, Ferdinando Squitieri.   

Abstract

We analyzed a population of juvenile Huntington disease (HD) subjects of Italian origin (n = 57). The main aim of this study was to analyze the gender effect of the affected parent on age at onset and clinical presentation of offspring with juvenile HD. We also analyzed molecular features of the disease, including CAG mutation length and GluR6 gene polymorphism, according to the affected parent's gender. The mutation length was longer in paternally than in maternally transmitted HD juvenile patients (P = 0.025), nevertheless a similar mean early onset in the two groups (P > 0.05). This data was even enforced by that obtained from the whole cohort of patients included in the databank (n = 600) where, in the presence of increased mean parent-child CAG repeat change in paternal vs. maternal meiotic transmissions (+7.3 vs. +0.7 CAG, P = 0.0002), the mean parent-child year-of-onset change was similar in the two groups (-10.4 and -7.0 years, P > 0.05). A lower TAA-triplet in GluR6 was associated with an earlier age at onset in juvenile patients (P = 0.031, R2 = 0.10). When we added the GluR6 effect on age at onset to the CAG expanded number effect (P = 0.0001, R2 = 0.68) by multiple regression approach, the coefficient of determination R2 increased to 0.81. This effect in addition to the expanded CAG repeat number, found in juvenile and not in adult patients, was slightly enforced by paternal compared to maternal transmissions (R2=0.82). Our findings suggest the occurrence of a weaker effect of the paternal mutation on juvenile age at onset in our population, possibly amplified by other genetic factors, such as the TAA-triplet length in the GluR6 gene. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755452     DOI: 10.1002/ajmg.b.20110

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  15 in total

1.  Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells.

Authors:  Ferdinando Squitieri; Vittorio Maglione; Sara Orobello; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2011-04-26       Impact factor: 3.575

2.  TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.

Authors:  Ji-Hyun Lee; Jong-Min Lee; Eliana Marisa Ramos; Tammy Gillis; Jayalakshmi S Mysore; Shotaro Kishikawa; Tiffany Hadzi; Audrey E Hendricks; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Ferdinando Squitieri; Cinzia Gellera; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Ruth K Abramson; Karen Marder; Jorge Sequeiros; G Bernhard Landwehrmeyer; Ira Shoulson; Richard H Myers; Marcy E MacDonald; James F Gusella
Journal:  Biochem Biophys Res Commun       Date:  2012-07-03       Impact factor: 3.575

3.  Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.

Authors:  J M Andresen; J Gayán; S S Cherny; D Brocklebank; G Alkorta-Aranburu; E A Addis; L R Cardon; D E Housman; N S Wexler
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

Review 4.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

5.  Managing juvenile Huntington's disease.

Authors:  Oliver W J Quarrell; Martha A Nance; Peggy Nopoulos; Jane S Paulsen; Jonathan A Smith; Ferdinando Squitieri
Journal:  Neurodegener Dis Manag       Date:  2013-06-01

6.  Early onset Huntington disease: a neuronal degeneration syndrome.

Authors:  Sara Seneca; Domique Fagnart; Kathelijn Keymolen; Willy Lissens; Daniele Hasaerts; Sara Debulpaep; Brigitte Desprechins; Inge Liebaers; Linda De Meirleir
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

7.  DNA instability in replicating Huntington's disease lymphoblasts.

Authors:  Milena Cannella; Vittorio Maglione; Tiziana Martino; Giuseppe Ragona; Luigi Frati; Guo-Min Li; Ferdinando Squitieri
Journal:  BMC Med Genet       Date:  2009-02-11       Impact factor: 2.103

8.  Current Pharmacological Management in Juvenile Huntington's Disease.

Authors:  Lisa Robertson; Helen Santini; Kirsty L O'Donovan; Ferdinando Squitieri; Roger A Barker; Maria Rakowicz; G Bernhard Landwehrmeyer; Oliver Quarrell
Journal:  PLoS Curr       Date:  2012-02-15

9.  Huntington's disease: the case for genetic modifiers.

Authors:  James F Gusella; Marcy E MacDonald
Journal:  Genome Med       Date:  2009-08-21       Impact factor: 11.117

10.  The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis.

Authors:  Oliver Quarrell; Kirsty L O'Donovan; Oliver Bandmann; Mark Strong
Journal:  PLoS Curr       Date:  2012-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.